HKU Gets Green Light For Nasal Covid Vaccine Trials
"); jQuery("#212 h3").html("
"); });
2020-09-09 HKT 19:19
Share this story
The University of Hong Kong says mainland authorities have allowed clinical trials of a nasal spray vaccine for Covid-19 it has been developing with mainland institutions.
The State Key Laboratory of Emerging Infectious Diseases of the university's Department of Microbiology has been working on the vaccine with Xiamen University and Beijing Wantai Biological Pharmacy.
It says it is the only nasally-administered vaccine against the disease to be allowed for clinical trials so far by the National Medical Products Administration.
Ant Internationals Ant Bank And Bettr Selected For Hong Kongs GenAI Sandbox++
Digital bank Ant Bank and embedded financial solutions provider Bettr have been selected to participate in Hong Kong’... Read more
Visa And BOCHK Tapped For Hong Kong AI Sandbox To Test Agent-Initiated Commerce
Visa has announced that it is partnering with Bank of China (Hong Kong) (BOCHK) in the GenA.I. Sandbox++. With the Visa... Read more
Hong Kong Regulators Pick 36 Agentic AI Use Cases For GenA.I. Sandbox++
The Hong Kong Monetary Authority (HKMA), the Securities and Futures Commission (SFC), the Insurance Authority (IA), and... Read more
Finloop And Yunfeng Financial Become Latest Anchorpoint Authorised Distributors
Finloop and Yunfeng Financial have joined Anchorpoint’s HKDAP stablecoin beta access programme as authorised distribu... Read more
Standard Chartered Becomes First Bank To Distribute HKDAP Stablecoin
Standard Chartered Bank (Hong Kong) Limited (SCBHK) has become the first bank distributor of HKDAP, the Hong Kong dolla... Read more
Lianlian DigiTech Profit Doubles In H12026, Agent Wallet Pushes To Address Payment Needs
Lianlian DigiTech Co., Ltd, a payment service provider headquartered in China, reported its interim results for the fir... Read more